Items tagged with Global TB response

Want to end TB? Diagnose and treat all forms of the disease (post)

Tuberculosis should be a specter of the past, something only our great-grandparents feared and died of. Alas, although almost all cases of TB today are both preventable and treatable, several different strains and manifestations of the disease still sicken and kill millions of people every year.

Antibiotic research priorities: ready, set, now go (post)

When faced with a medical emergency and limited resources, triage is essential. Deciding where needs are greatest helps to focus attention and provoke action, in line with a utilitarian aim of maximising gains and minimising harms for the greatest number of people. The importance of setting priorities applies equally to a global emergency as to a local one. With the threat of antimicrobial resistance now recognised at the highest political levels, WHO has compiled a list of pathogens on which research and development of new antimicrobials should be focused.

Regardless of the WHO snafu, TB should be a priority in the global AMR response (post)

On 27 February, the WHO published a list of antibiotic-resistant "priority pathogens." The first of its kind, this list is intended to promote research, discovery and development (R&D) of new antibiotics, as part of WHO’s efforts to address the threat of antimicrobial resistance (AMR) and respond to an urgent public health need. The hope is that the list will catalyse governments to incentivize basic science and advanced R&D.

Opinion pieces recognize World TB Day (post)

Tuberculosis and ‘failure’: Who should bear the label? (post)

Marking those who remain sick with the word “failure” implies that they themselves, rather than the disease, are to blame.

March 2017 issue of Public Health Action now online (post)

Public Health Action is the free access, online journal of The International Union Against Tuberculosis and Lung Disease. The journal focuses on tuberculosis, lung health, non-communicable diseases and related public health issues.

National Action Plan for Combating MDR-TB continues to be a work in progress (post)

In December 2015, tuberculosis response advocates welcomed the release of a White House National Action Plan for Combating Multidrug-Resistant Tuberculosis with wary optimism. Promised months earlier as part of a broader administration initiative to tackle antimicrobial resistance, a set of specific goals to counter the growing threat of tuberculosis that does not respond to available medicines would, advocates hoped, inspire funding to support improved treatment and diagnoses of the disease. At the same time, advocates noted, without that funding, the plan would remain nothing more than a plan. They pointed to an earlier initiative with the same name, released by the U.S. Centers for Disease Control and Prevention in 1992 that, unsupported by federal dollars, had never materialized into action or results. And they pointed out that, released in the final week of 2015, the plan had arrived too late to achieve goals that it had set, and aimed to meet “by 2016.”

←First 37 38 39 Last→